跳至主要内容
临床试验/CTRI/2024/01/061587
CTRI/2024/01/061587尚未招募2 期

Evaluation of Hypoglycemic activity (invitro) and clinical efficacy of Panchtikta Churna in Madhumeha (type 2 Diabetes Mellitus): A Preliminary Study - NI

Ayurvedic and Unani Tibbia college0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients of age group 18 to 60 years of either sex.
  • 2. Fasting plasma glucose = 126 mg/dl or Post Prandial glucose level = 200 mg/dl.
  • 3. The HbA1c levels should lie within the range of > 6.5% to <8.5%
  • ( According to American Diabetes Association, ADA ,2022 guidelines)

排除标准

  • 1. Patients having sign and symptoms of complication of Type 2 Diabetes Mellitus like Nephropathy,
  • Retinopathy, Neuropathy.
  • 2. Patients with gestational diabetes mellitus or pregnant women .
  • 3. Patients suffering from any chronic diseases such as Bronchial asthma , COPD, Chronic kidney disease ,
  • Ischaemic heart diseases , Fatty liver stage 3 and Chronic illness of other body organs , uncontrolled High
  • blood pressure (Systolic more than 160 and diastolic more than 100 mm of Hg)
  • 4. Patients who are diagnosed with malignancy of any system.
  • 5. Patients currently using oral hypoglycemic agents (Conventional).

研究者

相似试验